A detailed history of Byrne Asset Management LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 14,000 shares of PACB stock, worth $27,300. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,000
Previous 3,200 337.5%
Holding current value
$27,300
Previous $12,000 58.33%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$1.36 - $3.65 $14,688 - $39,420
10,800 Added 337.5%
14,000 $19,000
Q1 2024

Apr 22, 2024

BUY
$3.52 - $9.59 $11,264 - $30,688
3,200 New
3,200 $12,000
Q3 2022

Oct 19, 2022

BUY
$3.93 - $8.57 $7,231 - $15,768
1,840 Added 55.76%
5,140 $30,000
Q2 2022

Jul 20, 2022

BUY
$4.02 - $10.43 $13,265 - $34,419
3,300 New
3,300 $15,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.